Drug-Eluting Balloon-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Drug-Eluting Balloon-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Drug-Eluting Balloon industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Drug-Eluting Balloon 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Drug-Eluting Balloon worldwide and market share by regions, with company and product introduction, position in the Drug-Eluting Balloon market
Market status and development trend of Drug-Eluting Balloon by types and applications
Cost and profit status of Drug-Eluting Balloon, and marketing status
Market growth drivers and challenges
The report segments the global Drug-Eluting Balloon market as:
Global Drug-Eluting Balloon Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Drug-Eluting Balloon Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Type I
Type II
Global Drug-Eluting Balloon Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Treatment of In-stent Restenosis (ISR)
Treatment of Small Vessel Disease (SVD)
Treatment of Bifurcation Stenoses
Treatment of Primary Coronary Artery Disease
Global Drug-Eluting Balloon Market: Manufacturers Segment Analysis (Company and Product introduction, Drug-Eluting Balloon Sales Volume, Revenue, Price and Gross Margin):
Boston Scientific
Medtronic
Cook Medical
C.R. Bard
B. Braun
Eurocor GmbH
Blue Medical
Bayer
Aachen Resonance
Acrostak
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Drug-Eluting Balloon-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Drug-Eluting Balloon industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Drug-Eluting Balloon 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Drug-Eluting Balloon worldwide and market share by regions, with company and product introduction, position in the Drug-Eluting Balloon market
Market status and development trend of Drug-Eluting Balloon by types and applications
Cost and profit status of Drug-Eluting Balloon, and marketing status
Market growth drivers and challenges
The report segments the global Drug-Eluting Balloon market as:
Global Drug-Eluting Balloon Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Drug-Eluting Balloon Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Type I
Type II
Global Drug-Eluting Balloon Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Treatment of In-stent Restenosis (ISR)
Treatment of Small Vessel Disease (SVD)
Treatment of Bifurcation Stenoses
Treatment of Primary Coronary Artery Disease
Global Drug-Eluting Balloon Market: Manufacturers Segment Analysis (Company and Product introduction, Drug-Eluting Balloon Sales Volume, Revenue, Price and Gross Margin):
Boston Scientific
Medtronic
Cook Medical
C.R. Bard
B. Braun
Eurocor GmbH
Blue Medical
Bayer
Aachen Resonance
Acrostak
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF DRUG-ELUTING BALLOON
1.1 Definition of Drug-Eluting Balloon in This Report
1.2 Commercial Types of Drug-Eluting Balloon
1.2.1 Type I
1.2.2 Type II
1.3 Downstream Application of Drug-Eluting Balloon
1.3.1 Treatment of In-stent Restenosis (ISR)
1.3.2 Treatment of Small Vessel Disease (SVD)
1.3.3 Treatment of Bifurcation Stenoses
1.3.4 Treatment of Primary Coronary Artery Disease
1.4 Development History of Drug-Eluting Balloon
1.5 Market Status and Trend of Drug-Eluting Balloon 2013-2023
1.5.1 Global Drug-Eluting Balloon Market Status and Trend 2013-2023
1.5.2 Regional Drug-Eluting Balloon Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Drug-Eluting Balloon 2013-2017
2.2 Sales Market of Drug-Eluting Balloon by Regions
2.2.1 Sales Volume of Drug-Eluting Balloon by Regions
2.2.2 Sales Value of Drug-Eluting Balloon by Regions
2.3 Production Market of Drug-Eluting Balloon by Regions
2.4 Global Market Forecast of Drug-Eluting Balloon 2018-2023
2.4.1 Global Market Forecast of Drug-Eluting Balloon 2018-2023
2.4.2 Market Forecast of Drug-Eluting Balloon by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Drug-Eluting Balloon by Types
3.2 Sales Value of Drug-Eluting Balloon by Types
3.3 Market Forecast of Drug-Eluting Balloon by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Drug-Eluting Balloon by Downstream Industry
4.2 Global Market Forecast of Drug-Eluting Balloon by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Drug-Eluting Balloon Market Status by Countries
5.1.1 North America Drug-Eluting Balloon Sales by Countries (2013-2017)
5.1.2 North America Drug-Eluting Balloon Revenue by Countries (2013-2017)
5.1.3 United States Drug-Eluting Balloon Market Status (2013-2017)
5.1.4 Canada Drug-Eluting Balloon Market Status (2013-2017)
5.1.5 Mexico Drug-Eluting Balloon Market Status (2013-2017)
5.2 North America Drug-Eluting Balloon Market Status by Manufacturers
5.3 North America Drug-Eluting Balloon Market Status by Type (2013-2017)
5.3.1 North America Drug-Eluting Balloon Sales by Type (2013-2017)
5.3.2 North America Drug-Eluting Balloon Revenue by Type (2013-2017)
5.4 North America Drug-Eluting Balloon Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Drug-Eluting Balloon Market Status by Countries
6.1.1 Europe Drug-Eluting Balloon Sales by Countries (2013-2017)
6.1.2 Europe Drug-Eluting Balloon Revenue by Countries (2013-2017)
6.1.3 Germany Drug-Eluting Balloon Market Status (2013-2017)
6.1.4 UK Drug-Eluting Balloon Market Status (2013-2017)
6.1.5 France Drug-Eluting Balloon Market Status (2013-2017)
6.1.6 Italy Drug-Eluting Balloon Market Status (2013-2017)
6.1.7 Russia Drug-Eluting Balloon Market Status (2013-2017)
6.1.8 Spain Drug-Eluting Balloon Market Status (2013-2017)
6.1.9 Benelux Drug-Eluting Balloon Market Status (2013-2017)
6.2 Europe Drug-Eluting Balloon Market Status by Manufacturers
6.3 Europe Drug-Eluting Balloon Market Status by Type (2013-2017)
6.3.1 Europe Drug-Eluting Balloon Sales by Type (2013-2017)
6.3.2 Europe Drug-Eluting Balloon Revenue by Type (2013-2017)
6.4 Europe Drug-Eluting Balloon Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Drug-Eluting Balloon Market Status by Countries
7.1.1 Asia Pacific Drug-Eluting Balloon Sales by Countries (2013-2017)
7.1.2 Asia Pacific Drug-Eluting Balloon Revenue by Countries (2013-2017)
7.1.3 China Drug-Eluting Balloon Market Status (2013-2017)
7.1.4 Japan Drug-Eluting Balloon Market Status (2013-2017)
7.1.5 India Drug-Eluting Balloon Market Status (2013-2017)
7.1.6 Southeast Asia Drug-Eluting Balloon Market Status (2013-2017)
7.1.7 Australia Drug-Eluting Balloon Market Status (2013-2017)
7.2 Asia Pacific Drug-Eluting Balloon Market Status by Manufacturers
7.3 Asia Pacific Drug-Eluting Balloon Market Status by Type (2013-2017)
7.3.1 Asia Pacific Drug-Eluting Balloon Sales by Type (2013-2017)
7.3.2 Asia Pacific Drug-Eluting Balloon Revenue by Type (2013-2017)
7.4 Asia Pacific Drug-Eluting Balloon Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Drug-Eluting Balloon Market Status by Countries
8.1.1 Latin America Drug-Eluting Balloon Sales by Countries (2013-2017)
8.1.2 Latin America Drug-Eluting Balloon Revenue by Countries (2013-2017)
8.1.3 Brazil Drug-Eluting Balloon Market Status (2013-2017)
8.1.4 Argentina Drug-Eluting Balloon Market Status (2013-2017)
8.1.5 Colombia Drug-Eluting Balloon Market Status (2013-2017)
8.2 Latin America Drug-Eluting Balloon Market Status by Manufacturers
8.3 Latin America Drug-Eluting Balloon Market Status by Type (2013-2017)
8.3.1 Latin America Drug-Eluting Balloon Sales by Type (2013-2017)
8.3.2 Latin America Drug-Eluting Balloon Revenue by Type (2013-2017)
8.4 Latin America Drug-Eluting Balloon Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Drug-Eluting Balloon Market Status by Countries
9.1.1 Middle East and Africa Drug-Eluting Balloon Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Drug-Eluting Balloon Revenue by Countries (2013-2017)
9.1.3 Middle East Drug-Eluting Balloon Market Status (2013-2017)
9.1.4 Africa Drug-Eluting Balloon Market Status (2013-2017)
9.2 Middle East and Africa Drug-Eluting Balloon Market Status by Manufacturers
9.3 Middle East and Africa Drug-Eluting Balloon Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Drug-Eluting Balloon Sales by Type (2013-2017)
9.3.2 Middle East and Africa Drug-Eluting Balloon Revenue by Type (2013-2017)
9.4 Middle East and Africa Drug-Eluting Balloon Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF DRUG-ELUTING BALLOON
10.1 Global Economy Situation and Trend Overview
10.2 Drug-Eluting Balloon Downstream Industry Situation and Trend Overview
CHAPTER 11 DRUG-ELUTING BALLOON MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Drug-Eluting Balloon by Major Manufacturers
11.2 Production Value of Drug-Eluting Balloon by Major Manufacturers
11.3 Basic Information of Drug-Eluting Balloon by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Drug-Eluting Balloon Major Manufacturer
11.3.2 Employees and Revenue Level of Drug-Eluting Balloon Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 DRUG-ELUTING BALLOON MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Boston Scientific
12.1.1 Company profile
12.1.2 Representative Drug-Eluting Balloon Product
12.1.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Boston Scientific
12.2 Medtronic
12.2.1 Company profile
12.2.2 Representative Drug-Eluting Balloon Product
12.2.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Medtronic
12.3 Cook Medical
12.3.1 Company profile
12.3.2 Representative Drug-Eluting Balloon Product
12.3.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Cook Medical
12.4 C.R. Bard
12.4.1 Company profile
12.4.2 Representative Drug-Eluting Balloon Product
12.4.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of C.R. Bard
12.5 B. Braun
12.5.1 Company profile
12.5.2 Representative Drug-Eluting Balloon Product
12.5.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of B. Braun
12.6 Eurocor GmbH
12.6.1 Company profile
12.6.2 Representative Drug-Eluting Balloon Product
12.6.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Eurocor GmbH
12.7 Blue Medical
12.7.1 Company profile
12.7.2 Representative Drug-Eluting Balloon Product
12.7.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Blue Medical
12.8 Bayer
12.8.1 Company profile
12.8.2 Representative Drug-Eluting Balloon Product
12.8.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Bayer
12.9 Aachen Resonance
12.9.1 Company profile
12.9.2 Representative Drug-Eluting Balloon Product
12.9.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Aachen Resonance
12.10 Acrostak
12.10.1 Company profile
12.10.2 Representative Drug-Eluting Balloon Product
12.10.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Acrostak
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG-ELUTING BALLOON
13.1 Industry Chain of Drug-Eluting Balloon
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF DRUG-ELUTING BALLOON
14.1 Cost Structure Analysis of Drug-Eluting Balloon
14.2 Raw Materials Cost Analysis of Drug-Eluting Balloon
14.3 Labor Cost Analysis of Drug-Eluting Balloon
14.4 Manufacturing Expenses Analysis of Drug-Eluting Balloon
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Drug-Eluting Balloon in This Report
1.2 Commercial Types of Drug-Eluting Balloon
1.2.1 Type I
1.2.2 Type II
1.3 Downstream Application of Drug-Eluting Balloon
1.3.1 Treatment of In-stent Restenosis (ISR)
1.3.2 Treatment of Small Vessel Disease (SVD)
1.3.3 Treatment of Bifurcation Stenoses
1.3.4 Treatment of Primary Coronary Artery Disease
1.4 Development History of Drug-Eluting Balloon
1.5 Market Status and Trend of Drug-Eluting Balloon 2013-2023
1.5.1 Global Drug-Eluting Balloon Market Status and Trend 2013-2023
1.5.2 Regional Drug-Eluting Balloon Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Drug-Eluting Balloon 2013-2017
2.2 Sales Market of Drug-Eluting Balloon by Regions
2.2.1 Sales Volume of Drug-Eluting Balloon by Regions
2.2.2 Sales Value of Drug-Eluting Balloon by Regions
2.3 Production Market of Drug-Eluting Balloon by Regions
2.4 Global Market Forecast of Drug-Eluting Balloon 2018-2023
2.4.1 Global Market Forecast of Drug-Eluting Balloon 2018-2023
2.4.2 Market Forecast of Drug-Eluting Balloon by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Drug-Eluting Balloon by Types
3.2 Sales Value of Drug-Eluting Balloon by Types
3.3 Market Forecast of Drug-Eluting Balloon by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Drug-Eluting Balloon by Downstream Industry
4.2 Global Market Forecast of Drug-Eluting Balloon by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Drug-Eluting Balloon Market Status by Countries
5.1.1 North America Drug-Eluting Balloon Sales by Countries (2013-2017)
5.1.2 North America Drug-Eluting Balloon Revenue by Countries (2013-2017)
5.1.3 United States Drug-Eluting Balloon Market Status (2013-2017)
5.1.4 Canada Drug-Eluting Balloon Market Status (2013-2017)
5.1.5 Mexico Drug-Eluting Balloon Market Status (2013-2017)
5.2 North America Drug-Eluting Balloon Market Status by Manufacturers
5.3 North America Drug-Eluting Balloon Market Status by Type (2013-2017)
5.3.1 North America Drug-Eluting Balloon Sales by Type (2013-2017)
5.3.2 North America Drug-Eluting Balloon Revenue by Type (2013-2017)
5.4 North America Drug-Eluting Balloon Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Drug-Eluting Balloon Market Status by Countries
6.1.1 Europe Drug-Eluting Balloon Sales by Countries (2013-2017)
6.1.2 Europe Drug-Eluting Balloon Revenue by Countries (2013-2017)
6.1.3 Germany Drug-Eluting Balloon Market Status (2013-2017)
6.1.4 UK Drug-Eluting Balloon Market Status (2013-2017)
6.1.5 France Drug-Eluting Balloon Market Status (2013-2017)
6.1.6 Italy Drug-Eluting Balloon Market Status (2013-2017)
6.1.7 Russia Drug-Eluting Balloon Market Status (2013-2017)
6.1.8 Spain Drug-Eluting Balloon Market Status (2013-2017)
6.1.9 Benelux Drug-Eluting Balloon Market Status (2013-2017)
6.2 Europe Drug-Eluting Balloon Market Status by Manufacturers
6.3 Europe Drug-Eluting Balloon Market Status by Type (2013-2017)
6.3.1 Europe Drug-Eluting Balloon Sales by Type (2013-2017)
6.3.2 Europe Drug-Eluting Balloon Revenue by Type (2013-2017)
6.4 Europe Drug-Eluting Balloon Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Drug-Eluting Balloon Market Status by Countries
7.1.1 Asia Pacific Drug-Eluting Balloon Sales by Countries (2013-2017)
7.1.2 Asia Pacific Drug-Eluting Balloon Revenue by Countries (2013-2017)
7.1.3 China Drug-Eluting Balloon Market Status (2013-2017)
7.1.4 Japan Drug-Eluting Balloon Market Status (2013-2017)
7.1.5 India Drug-Eluting Balloon Market Status (2013-2017)
7.1.6 Southeast Asia Drug-Eluting Balloon Market Status (2013-2017)
7.1.7 Australia Drug-Eluting Balloon Market Status (2013-2017)
7.2 Asia Pacific Drug-Eluting Balloon Market Status by Manufacturers
7.3 Asia Pacific Drug-Eluting Balloon Market Status by Type (2013-2017)
7.3.1 Asia Pacific Drug-Eluting Balloon Sales by Type (2013-2017)
7.3.2 Asia Pacific Drug-Eluting Balloon Revenue by Type (2013-2017)
7.4 Asia Pacific Drug-Eluting Balloon Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Drug-Eluting Balloon Market Status by Countries
8.1.1 Latin America Drug-Eluting Balloon Sales by Countries (2013-2017)
8.1.2 Latin America Drug-Eluting Balloon Revenue by Countries (2013-2017)
8.1.3 Brazil Drug-Eluting Balloon Market Status (2013-2017)
8.1.4 Argentina Drug-Eluting Balloon Market Status (2013-2017)
8.1.5 Colombia Drug-Eluting Balloon Market Status (2013-2017)
8.2 Latin America Drug-Eluting Balloon Market Status by Manufacturers
8.3 Latin America Drug-Eluting Balloon Market Status by Type (2013-2017)
8.3.1 Latin America Drug-Eluting Balloon Sales by Type (2013-2017)
8.3.2 Latin America Drug-Eluting Balloon Revenue by Type (2013-2017)
8.4 Latin America Drug-Eluting Balloon Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Drug-Eluting Balloon Market Status by Countries
9.1.1 Middle East and Africa Drug-Eluting Balloon Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Drug-Eluting Balloon Revenue by Countries (2013-2017)
9.1.3 Middle East Drug-Eluting Balloon Market Status (2013-2017)
9.1.4 Africa Drug-Eluting Balloon Market Status (2013-2017)
9.2 Middle East and Africa Drug-Eluting Balloon Market Status by Manufacturers
9.3 Middle East and Africa Drug-Eluting Balloon Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Drug-Eluting Balloon Sales by Type (2013-2017)
9.3.2 Middle East and Africa Drug-Eluting Balloon Revenue by Type (2013-2017)
9.4 Middle East and Africa Drug-Eluting Balloon Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF DRUG-ELUTING BALLOON
10.1 Global Economy Situation and Trend Overview
10.2 Drug-Eluting Balloon Downstream Industry Situation and Trend Overview
CHAPTER 11 DRUG-ELUTING BALLOON MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Drug-Eluting Balloon by Major Manufacturers
11.2 Production Value of Drug-Eluting Balloon by Major Manufacturers
11.3 Basic Information of Drug-Eluting Balloon by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Drug-Eluting Balloon Major Manufacturer
11.3.2 Employees and Revenue Level of Drug-Eluting Balloon Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 DRUG-ELUTING BALLOON MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Boston Scientific
12.1.1 Company profile
12.1.2 Representative Drug-Eluting Balloon Product
12.1.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Boston Scientific
12.2 Medtronic
12.2.1 Company profile
12.2.2 Representative Drug-Eluting Balloon Product
12.2.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Medtronic
12.3 Cook Medical
12.3.1 Company profile
12.3.2 Representative Drug-Eluting Balloon Product
12.3.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Cook Medical
12.4 C.R. Bard
12.4.1 Company profile
12.4.2 Representative Drug-Eluting Balloon Product
12.4.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of C.R. Bard
12.5 B. Braun
12.5.1 Company profile
12.5.2 Representative Drug-Eluting Balloon Product
12.5.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of B. Braun
12.6 Eurocor GmbH
12.6.1 Company profile
12.6.2 Representative Drug-Eluting Balloon Product
12.6.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Eurocor GmbH
12.7 Blue Medical
12.7.1 Company profile
12.7.2 Representative Drug-Eluting Balloon Product
12.7.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Blue Medical
12.8 Bayer
12.8.1 Company profile
12.8.2 Representative Drug-Eluting Balloon Product
12.8.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Bayer
12.9 Aachen Resonance
12.9.1 Company profile
12.9.2 Representative Drug-Eluting Balloon Product
12.9.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Aachen Resonance
12.10 Acrostak
12.10.1 Company profile
12.10.2 Representative Drug-Eluting Balloon Product
12.10.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Acrostak
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG-ELUTING BALLOON
13.1 Industry Chain of Drug-Eluting Balloon
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF DRUG-ELUTING BALLOON
14.1 Cost Structure Analysis of Drug-Eluting Balloon
14.2 Raw Materials Cost Analysis of Drug-Eluting Balloon
14.3 Labor Cost Analysis of Drug-Eluting Balloon
14.4 Manufacturing Expenses Analysis of Drug-Eluting Balloon
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
